reports
Prelude Therapeutics Reports First Quarter 2024 Financial Results and ...
Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update First-in-class IV SMARCA2 degrader, PRT3789 and potentially best-in-class CDK9 inhibitor, PRT2527 remain on track to generate initial proof-of-concept data in 2024 New preclinical data presented at AACR 2024 included first characterization of PRT7732, a highly-selective, orally bioavailable SMARCA2 degrader Operational leadership capabilities further strengthened by recent hires Chief Business Officer Sean Brusky and Senior Vice President, Investor Relations Robert Doody Current cash runway ...
First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Re...
First Watch Restaurant Group, Inc. Reports Strong Q1 2024 Financial Results Total revenues increased 14.7%; same-restaurant sales growth of 0.5%*Income from operations margin of 5.1% and restaurant level operating profit margin of 20.8%Net income of $7.2 million and Adjusted EBITDA of $28.6 million9 system-wide restaurants opened across 8 states BRADENTON, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today reported financial results for...
BioCryst to Present at Upcoming Investor Conferences
BioCryst to Present at Upcoming Investor Conferences RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the company will present at the following conferences: Citizens JMP Life Sciences Conference in New York on Monday, May 13, 2024, at 12:30 p.m. ET. 2024 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 14, 2024, at 3:05 p.m. ET. Bank of America Health Care Conference 2024 in Las Vegas on Wednesday, May 15, 2024, at 5:20 p.m. ET. H.C. Wainwright 2nd Annual BioConnect Investor Conference in New York on Monday...
Meritage Homes Announces Pricing of Convertible Senior Notes
Meritage Homes Announces Pricing of Convertible Senior Notes SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) -- Meritage Homes Corporation (NYSE: MTH, “Meritage” or the “Company”), the fifth-largest homebuilder in the U.S., today announced the pricing of $500 million aggregate principal amount of its 1.75% Convertible Senior Notes due 2028 (the “notes”). The Company also granted the initial purchasers of the notes a 13-day option to purchase up to $75 million of aggregate principal amount of additional notes. The sale of the notes is expected to settle on May 9, 2024, subject to customar...
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024 Eight presentations showcase the broad applicability of HSC gene therapy to address rare neurometabolic diseases and beyond TOKYO, LONDON and BOSTON, May 07, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced four oral and four poster presentations from across its hematopoietic stem cell (HSC) gene therapy platform will be featured at the 27th Annual Meeting of the American Society ...
Arvinas Reports First Quarter 2024 Financial Results and Provides Corp...
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update – Continued enrollment globally in multiple clinical studies of vepdegestrant in ER+/HER2- metastatic breast cancer, including the VERITAC-2 Phase 3 trial in the second-line setting and the study lead-in for the VERITAC-3 Phase 3 trial in the first-line setting – – Top-line data readout for VERITAC-2 remains on-track for 2H 2024 – – Entered a transaction with Novartis providing an exclusive license for ARV-766 and sale of preclinical AR-V7 program; $150 million upfront payment and potential for up to $1.01 ...
InspireMD to Report First Quarter 2024 Financial Results and Provide C...
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th -Conference call and webcast to be held at 8:30 a.m. EDT- TEL AVIV, Israel and MIAMI, May 07, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, announced today it will report first quarter 2024 financial results on Tuesday, May 14th, before the financial markets open. Management will host a conference call and webcast with the i...
Akoustis to Webcast Q3FY24 Results on May 13 at 8:00 am ET
Akoustis to Webcast Q3FY24 Results on May 13 at 8:00 am ET Charlotte, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, will webcast its Q3FY24 results on Monday, May 13, 2024, at 8:00 am Eastern Time. Management will host a question-and-answer session at the end of the call. To listen to the call by telephone, please dial 877-407-3982 (domestic) or 201-493-6780 (international). The con...
Dorman Products, Inc. Reports First Quarter 2024 Results
Dorman Products, Inc. Reports First Quarter 2024 Results Highlights (All comparisons are to the prior year period unless otherwise noted): Net sales of $468.7 million, up 0.4% compared to $466.7 millionDiluted earnings per share (“EPS”) of $1.05, up 483% compared to $0.18Adjusted diluted EPS* of $1.31, up 134% compared to $0.56Generated $52 million of cash from operating activities; repaid $15 million of debt and repurchased $27 million of its sharesThe Company confirms its full-year 2024 guidance COLMAR, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (the “Company” or ...
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Confere...
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conference on Tuesday, May 14, 2024, at 2:35 p.m. EDT. A live webcast of the event will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at . A replay of the webcast will be a...
Blade Air Mobility Reports Financial Results for the First Quarter End...
Blade Air Mobility Reports Financial Results for the First Quarter Ended March 31, 2024 Achieved record-high Medical revenue of $36.0 million in Q1 2024, a 34.6% increase versus the prior year period and a 12.6% sequential increase versus Q4 2023.Net loss improved by $6.0 million versus the prior year to $(4.2) million in Q1 2024; Adjusted EBITDA improved by $4.2 million versus the prior year to $(3.5) million in Q1 2024.Record-high Medical Segment Adjusted EBITDA of $4.4 million in Q1 2024, up 134.5%, while Passenger Segment Adjusted EBITDA improved by $0.4 million, versus the prior year p...
Solid Biosciences to Present at the American Society of Gene and Cell ...
Solid Biosciences to Present at the American Society of Gene and Cell Therapy Annual Meeting — Presentations to highlight AAV manufacturing and purification improvements, vector biology updates,and a comprehensive non-clinical data overview of the company’s lead SGT-003 program — CHARLESTOWN, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, will present an oral presentation and six posters and at the American Society of Gene and Cell Therapy (ASGCT) 2024 ...
Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conf...
Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024 BOSTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Tuesday, May 14, 2024, at 4:30 p.m. ET to report financial results for the first quarter ended March 31, 2024, and to provide a business update. To access the live conference ...
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights a...
Theriva™ Biologics Reports First Quarter 2024 Operational Highlights and Financial Results - Reported topline data from the investigator sponsored Phase 1 trial of intravitreal VCN-01 in pediatric patients with refractory retinoblastoma; trial results were determined to be positive by the study Monitoring Committee- -Presented preclinical data demonstrating the potential synergy between VCN-01 and liposomal irinotecan in a human pancreatic mouse xenograft at the ASGCT Annual Meeting; emphasizes VCN-01’s potential in diverse chemotherapy combinations for improved efficacy in pancreatic canc...
Chicago Atlantic Real Estate Finance Announces First Quarter 2024 Fina...
Chicago Atlantic Real Estate Finance Announces First Quarter 2024 Financial Results CHICAGO, May 07, 2024 (GLOBE NEWSWIRE) -- Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI) (“Chicago Atlantic” or the “Company”), a commercial mortgage real estate investment trust, today announced its results for the first quarter ended March 31, 2024. John Mazarakis, Executive Chairman of Chicago Atlantic, noted, “We are thrilled with progress toward regulatory reform resulting from the recent news of the DEA’s commitment to the rescheduling of cannabis. Once enacted, the policy change is likel...
Solaris Provides Update on Warintza Operations, Optimization Progress,...
Solaris Provides Update on Warintza Operations, Optimization Progress, and Appointment of Leading Consultants for the EIA and PFS VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to provide an operations update, including site optimization efforts that have resulted in significantly improved productivity and cost savings under new Chief Operating Officer (“COO”), Mr. Javier Toro, as well as the appointment of leading independent consultants in support of the Environmental Impact Assessment (...
Bioventus Reports First Quarter Financial Results
Bioventus Reports First Quarter Financial Results Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic PrioritiesAccelerated First Quarter Revenue Growth by 8.7%, Organic Growth* by 15.3%Gross Margin Expanded 620 bps and Adjusted Gross Margin* 190 bps DURHAM, N.C., May 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, today reported financial results for the three months ended March 30, 2024. “We are pleased with the strong start to the year...
XPO Opens New Service Center in Las Vegas to Expand Trade Show Shippin...
XPO Opens New Service Center in Las Vegas to Expand Trade Show Shipping and Strengthen Freight Transportation Across the Region XPO’s Second Location in Las Vegas Joins Recently Opened Facilities in Rapidly Growing Freight Markets GREENWICH, Conn., May 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: XPO), a leading provider of LTL freight transportation in North America, today announced the opening of a major new freight transportation center in Las Vegas that will serve as a linchpin for the company’s expanded . The new site, XPO’s second in Las Vegas, also enables faster service to local custom...
Antelope Enterprise Announces Rescheduling of its Second Half and Fisc...
Antelope Enterprise Announces Rescheduling of its Second Half and Fiscal Year End 2023 Earnings Conference Call NEW YORK, May 07, 2024 (GLOBE NEWSWIRE) -- Antelope Enterprise Holdings Limited (NASDAQ Capital Market: AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”), which operates KylinCloud, a livestreaming ecommerce business in China with access to 800,000+ hosts and influencers, today announced that it will reschedule its conference call that was scheduled for Tuesday, May 7, 2024 at 8:00 am ET. Further details will be forthcoming as to the new conference call date and time. ...
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Pl...
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement IRVINE, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that it has entered into a securities purchase agreement with certain institutional and accredited healthcare investors for a private investment in public equity financing that is expected to result in gross proceeds of approximately $50 million, before deducting offering expenses. Pursuant to the terms of the securities purchase agreement, Eledon is selling an aggregate of 13,110,484 shares of...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.